Hhlr Advisors, Ltd. Instil Bio, Inc. Transaction History

Hhlr Advisors, Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $10 Million - $26.6 Million	-2,385,457 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $57.8 Million - $64.6 Million	2,385,457 New	2,385,457 $59.8 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.